AURX

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Nuo Therapeutics (AURX) Ownership - Who owns Nuo Therapeutics?

Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

8285 El Rio

Phone

+1 346 396-4770

Employees

Web

https://www.nuot.com

Details

Group

Domestic Stock Funds

Fundamentals

AURX

Capitalization

71.2M

P/E Ratio

N/A

Risk (Beta)

-795.83

Dividend Yield

N/A

Total Cash

684K

Total Cash/Share

0.01

Total Debt

179K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.04%

Revenue

1.17M

ROE

N/A

Book Value

890K

P/B Ratio

149.25

Cash Flow

N/A

Earnings

-0.06

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

4.66K

Current Ratio

1.88

Current Revenue Per Employee

41216.78

Dividends Per Share - Security

N/A

EBITDA

-2.39M

Float

N/A

Float - Current

N/A

Gross Income Margin

72.91

Revenue To Assets

-149.45

Shares Held By Institutions

6.58K

Shares Outstanding - Current

46.8M

Total Liabilities

829K

Total Volume MTD

N/A

Value

-1

Gain YTD

8.571

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology